Bhatnagar Anish Soleno Therapeutics Inc (SLNO) insider trading activity

Bhatnagar Anish is CHIEF EXECUTIVE OFFICER of SOLENO THERAPEUTICS INC. Currently has a direct ownership of 719,553 shares of SLNO, which is worth approximately $39.3 Million. The most recent transaction as insider was on Oct 01, 2024, when has been sold 21,633 shares (Common Stock) at a price of $49.8 per share, resulting in proceeds of $1,077,323. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 720K

26.84% 3M change

261.72% 12M change

Total Value Held $39.3 Million

Bhatnagar Anish Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Oct 01 2024	SELL Open market or private sale	$1,077,323 $49.8 p/Share	21,633 Reduced 2.92%	719,553 Common Stock
Aug 29 2024	SELL Open market or private sale	$2,773,572 $47.5 p/Share	58,391 Reduced 7.3%	741,186 Common Stock
Aug 28 2024	SELL Open market or private sale	$2,695,344 $47.61 p/Share	56,613 Reduced 6.61%	799,577 Common Stock
Aug 06 2024	SELL Open market or private sale	$3,106,055 $44.93 p/Share	69,131 Reduced 7.47%	856,190 Common Stock
Aug 05 2024	SELL Open market or private sale	$2,666,737 $45.81 p/Share	58,213 Reduced 5.92%	925,321 Common Stock
Jul 17 2024	BUY Grant, award, or other acquisition	-	850,000 Added 46.36%	983,534 Common Stock
Jul 01 2024	SELL Open market or private sale	$797,776 $41.43 p/Share	19,256 Reduced 12.6%	133,534 Common Stock
Apr 01 2024	SELL Open market or private sale	$785,582 $41.39 p/Share	18,980 Reduced 11.05%	152,790 Common Stock
Jan 25 2024	SELL Open market or private sale	$122,054 $48.3 p/Share	2,527 Reduced 1.45%	171,770 Common Stock
Jan 04 2024	BUY Grant, award, or other acquisition	-	150,000 Added 46.25%	174,297 Common Stock
Dec 11 2023	SELL Open market or private sale	$3,371,094 $36.09 p/Share	93,408 Reduced 79.36%	24,297 Common Stock
Nov 30 2023	SELL Open market or private sale	$794,063 $28.65 p/Share	27,716 Reduced 20.41%	108,062 Common Stock
Nov 29 2023	SELL Open market or private sale	$774,981 $27.85 p/Share	27,827 Reduced 17.01%	135,778 Common Stock
Nov 28 2023	SELL Open market or private sale	$701,266 $27.31 p/Share	25,678 Reduced 13.57%	163,605 Common Stock
Oct 20 2023	BUY Exercise of conversion of derivative security	$28,157 $2.92 p/Share	9,643 Added 4.62%	198,926 Common Stock
May 26 2023	BUY Grant, award, or other acquisition	-	160,602 Added 45.9%	189,283 Common Stock
Mar 31 2022	BUY Open market or private purchase	-	60,000 Added 12.24%	430,227 Common Stock
Jan 21 2022	SELL Open market or private sale	$14,442 $0.37 p/Share	39,033 Reduced 9.54%	370,227 Common Stock
Jan 23 2021	SELL Payment of exercise price or tax liability	$76,631 $2.11 p/Share	36,318 Reduced 0.89%	4,060,780 Common Stock

Bhatnagar Anish

CHIEF EXECUTIVE OFFICER

Redwood City, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SLNO shares.

Notify only if

Value

Insider Trading

Get notified when an Soleno Therapeutics Inc insider buys or sells SLNO shares.

Notify only if

Operation

Value

Type

News

Receive news related to SOLENO THERAPEUTICS INC

Track Activities on SLNO

Account